Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
BIO-key and Fiber Food Systems Inc. Collaborate to Enhance Security and Efficiency in the Food Tech Sector
08:29am, Monday, 02'nd Dec 2024
BIO-key (BKYI) & Fiber Food Systems Inc. Collaborate to Enhance Security & Efficiency in Food Tech Sector. Transaction Strengthens BIO-key's Balance Sheet.
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
07:00am, Wednesday, 27'th Nov 2024
MINNEAPOLIS , Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Health
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
07:00am, Wednesday, 20'th Nov 2024
MINNEAPOLIS , Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagno
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
07:00am, Monday, 18'th Nov 2024
MINNEAPOLIS , Nov. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease re
BIO-key (BKYI) Reports Q3'24 Revenue Rose 18% to $2.1M, Reduced Q3'24 Net Loss, Improved Cash Position; Hosts Conf. Call Tomorrow, Fri. Nov. 15th, 10am ET.
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
07:00am, Thursday, 14'th Nov 2024
Customers will present data from their use of novel assays and kits; company will host educational workshops and discussions for attendees MINNEAPOLIS , Nov. 14, 2024 /PRNewswire/ -- Bio-Techne Corpor
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
05:47pm, Monday, 11'th Nov 2024
R&D Systems Hematology Controls and Calibrators has completed the Class B Certification under the new European Union In Vitro Diagnostic Regulation This press release updates the IVDR Classification
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
07:00am, Monday, 11'th Nov 2024
R&D Systems Hematology Controls and Calibrators has completed the Class C Certification under the new European Union In Vitro Diagnostic Regulation MINNEAPOLIS , Nov. 11, 2024 /PRNewswire/ -- Bio-Te
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
07:00am, Friday, 08'th Nov 2024
MINNEAPOLIS , Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: UBS Global Healthcare Conference November 1
Interpreting Bio-Rad (BIO) International Revenue Trends
10:22am, Monday, 04'th Nov 2024
Examine the evolution of Bio-Rad's (BIO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Tiziana Life Sciences to showcase breakthrough therapies at BIO-Europe 2024 Conference
04:31pm, Friday, 01'st Nov 2024
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it will participate in the upcoming BIO-Europe 2024 conference in Stockholm. The event will allow Tiziana to engage with industry leaders, potential collab
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket
09:46am, Thursday, 31'st Oct 2024
Bio-Rad witnesses growth across the Clinical Diagnostics segment in the third quarter, primarily driven by an increased demand for quality control and immunology products.
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
09:00am, Thursday, 31'st Oct 2024
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chie
Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript
08:22pm, Wednesday, 30'th Oct 2024
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Edward Chung - Vice President of Investor Relations Norman Schwartz - Chairman
